Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Ferrante

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Peptide-MHC class II complex stability governs CD4 T cell clonal selectionChristina K Baumgartner, Andrea Ferrante, Mika Nagaoka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2011
Naive T cell repertoire skewing in HLA-A2 individuals by a specialized rearrangement mechanism results in public memory clonotypesMaryam Yassai, Dmitry Bosenko, Melissa Unruh, et al.
Journal of Immunological Methods|September 11, 2021
Comparability study of monocyte derived dendritic cells, primary monocytes, and THP1 cells for innate immune responsesYi Wen, Xiaoli Wang, Suntara Cahya, et al.
Cell Reports|November 24, 2016
Nfix Induces a Switch in Sox6 Transcriptional Activity to Regulate MyHC-I Expression in Fetal MuscleValentina Taglietti, Giovanni Maroli, Solei Cermenati, et al.
Journal of Immunological Methods|August 13, 2018
Enhanced quantification of serum immunoglobulin G from a non-model wildlife species, the Steller sea lion (Eumetopias jubatus), using a protein A ELISAStephanie N Kennedy, Brittany Wilhite, J Margaret Castellini, et al.
The AAPS Journal|April 18, 2020
Development of a FRET-Based Assay for Analysis of mAbs Internalization and Processing by Dendritic Cells in Preclinical Immunogenicity Risk AssessmentYi Wen, Suntara Cahya, Wei Zeng, et al.
Plos One|July 23, 2021
A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeuticsJoanne Lin, Stacey L Lee, Anna M Russell, et al.
The AAPS Journal|March 6, 2025
A Phase-Appropriate Risk Assessment Strategy in Support of the Safety of Peptide and Oligonucleotide-Related ImpuritiesBrian W Pack, Robert W Siegel, Paul D Cornwell, et al.
Clinical Transplantation|September 4, 2004
Cytokine mRNA expression in chronically rejected human renal allograftsArcangelo Nocera, Augusto Tagliamacco, Raffaele De Palma, et al.
Clinical Pharmacology in Drug Development|January 19, 2026
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 StudiesAndrew C Vendel, Olivier Benichou, Ching-Yun Chang, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|December 17, 2009
Peptide-MHC class II complex stability governs CD4 T cell clonal selectionChristina K Baumgartner, Andrea Ferrante, Mika Nagaoka, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 2, 2011
Naive T cell repertoire skewing in HLA-A2 individuals by a specialized rearrangement mechanism results in public memory clonotypesMaryam Yassai, Dmitry Bosenko, Melissa Unruh, et al.
Journal of Immunological Methods|September 11, 2021
Comparability study of monocyte derived dendritic cells, primary monocytes, and THP1 cells for innate immune responsesYi Wen, Xiaoli Wang, Suntara Cahya, et al.
Cell Reports|November 24, 2016
Nfix Induces a Switch in Sox6 Transcriptional Activity to Regulate MyHC-I Expression in Fetal MuscleValentina Taglietti, Giovanni Maroli, Solei Cermenati, et al.
Journal of Immunological Methods|August 13, 2018
Enhanced quantification of serum immunoglobulin G from a non-model wildlife species, the Steller sea lion (Eumetopias jubatus), using a protein A ELISAStephanie N Kennedy, Brittany Wilhite, J Margaret Castellini, et al.
The AAPS Journal|April 18, 2020
Development of a FRET-Based Assay for Analysis of mAbs Internalization and Processing by Dendritic Cells in Preclinical Immunogenicity Risk AssessmentYi Wen, Suntara Cahya, Wei Zeng, et al.
Plos One|July 23, 2021
A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeuticsJoanne Lin, Stacey L Lee, Anna M Russell, et al.
The AAPS Journal|March 6, 2025
A Phase-Appropriate Risk Assessment Strategy in Support of the Safety of Peptide and Oligonucleotide-Related ImpuritiesBrian W Pack, Robert W Siegel, Paul D Cornwell, et al.
Clinical Transplantation|September 4, 2004
Cytokine mRNA expression in chronically rejected human renal allograftsArcangelo Nocera, Augusto Tagliamacco, Raffaele De Palma, et al.
Clinical Pharmacology in Drug Development|January 19, 2026
Safety, Tolerability, Pharmacokinetics, and Immunogenicity of a BTLA Agonist Antibody (Venanprubart) in Healthy Participants, Patients with Systemic Lupus Erythematosus, and Patients with Psoriasis: Results From Three Phase 1 StudiesAndrew C Vendel, Olivier Benichou, Ching-Yun Chang, et al.
Pageof 3